Charles Bramlage's Net Worth
-$423 Thousand
Who is Charles Bramlage?
Charles Bramlage does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Eiger BioPharmaceuticals, Inc., and VALEANT PHARMACEUTICALS INTERNATIONAL.
SEC CIK
Charles Bramlage's CIK is 0001314000
Past Insider Trading and Trends
2016 was Charles Bramlage's most active year for acquiring shares with 7 total transactions. Charles Bramlage's most active month to acquire stocks was the month of July. 2015 was Charles Bramlage's most active year for disposing of shares, totalling 2 transactions. Charles Bramlage's most active month to dispose stocks was the month of July. 2007 saw Charles Bramlage paying a total of $370,000.00 for 75,000 shares, this is the most they've acquired in one year. In 2016 Charles Bramlage cashed out on 25,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
InvestorCharles Bramlage owns 83,150 units of Common Stock.acquired a total of 83,150 shares in BIODELIVERY SCIENCES INTERNATIONAL INC at a cost of $49,887.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56.44% | 30K |
—
|
—
| 83.15K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
| +88.81% | 25K |
—
|
—
| 53.15K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +45.85% | 8.85K |
$2.82 | $24,957.00 | 28.15K |
Mar 21
| |||
Form 4
| +972.22% | 17.5K |
—
|
—
| 19.3K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
|
∞
| 1.8K |
$13.85 | $24,930.00 | 1.8K |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VALEANT PHARMACEUTICALS INTERNATIONAL No price found
President, EuropeCharles Bramlage owns 25,000 units of Common Stock and 180 units of Dividend Equivalent Rights. In the year 2005 Charles Bramlage filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
$14.80 | $370,000.00 | 25K |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| +28.57% | 40 |
$19.66 | $786.40 | 180 |
Aug 31
| |||
Form 4
| +45.83% | 44 |
$17.61 | $774.84 | 140 |
Jun 1
| |||
Form 4
| +104.26% | 49 |
$15.86 | $777.14 | 96 |
Mar 30
| |||
Form 4
|
∞
| 47 |
$16.46 | $773.62 | 47 |
Dec 1
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||